Cochin Shipyard to invest Rs 50cr in maritime start-ups
Cochin Shipyard, an Indian government-owned shipbuilding and maintenance company, will invest an initial corpus of INR 50 crores in start-ups engaged in the maritime sector. ... Read More
Cara Therapeutics, VFMCRP get EC approval for Kapruvia for pruritus
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) said that Kapruvia (difelikefalin) has secured approval from the European Commission (EC) for the treatment ... Read More
India’s first hydrogen fuel cell vessels to be built at Cochin Shipyard
Cochin Shipyard Limited said that the Indian Ministry of Ports, Shipping and Waterways has decided to develop and build indigenous hydrogen fuelled electric vessels at ... Read More
Campari Group brings Aperol Spritz ready-to-serve to Ontario and Quebec
Campari Group Canada said that Italian orange bittersweet aperitif Aperol has launched a new Aperol Spritz ready-to-serve format in Ontario and Quebec. The pre-mixed cocktail, ... Read More
Marel to buy pet food and aqua feed supplier Wenger Manufacturing for $540m
Marel has agreed to acquire Wenger Manufacturing, an American supplier of pet food, plant-based proteins, and aqua feed, for $540 million. According to the Iceland-based ... Read More
US-based Hersha Hospitality Trust to sell seven non-core hotels for $505m
Hersha Hospitality Trust has signed a deal worth $505 million with an undisclosed party to divest seven of its non-core Urban Select Service properties located ... Read More
Biocon Q4FY22 results : Indian pharma firm net profit down by 6% to Rs 239cr
Biocon Q4FY22 results : Biocon Ltd has reported a net profit of INR 239 crores for the fourth quarter of the fiscal year 2022 (Q4FY22), ... Read More
Infosys to help Nu Skin Enterprises transform beauty and wellness sector
Infosys has entered into a collaboration with Nu Skin Enterprises, an American multilevel marketing company, to help the latter drive social commerce-led transformation in the ... Read More
GSK to acquire US biopharma company Sierra Oncology for $1.9bn
GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9 billion (£1.5 billion). As per the terms ... Read More
Dr. Reddy’s Labs launches Posaconazole Delayed-Release Tablets in US
Dr. Reddy’s Laboratories said that it has launched Posaconazole Delayed-Release Tablets, 100 mg, a triazole antifungal drug, in the US market. Posaconazole Delayed-Release Tablets is ... Read More